Cloning and characterization of a naturally occurring soluble form of TGF-β type I receptor

American Journal of Physiology - Renal Physiology

Volumn 276, Issue 1 45-1, 1999, Pages

  Choi, Mary E ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alternative splicing; Renal development; Signaling; Transforming growth factor 1; Variant activin receptor like kinase 5

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL TISSUE; ARTICLE; CELL SURFACE; KIDNEY DEVELOPMENT; KIDNEY DISEASE; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 0032918977     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.1999.276.1.f88     Document Type: Article

References (28)

1. Attisano, L., J. Cárcamo, F. Ventura, F. M. B. Weis, J. Massagué, and J. L. Wrana. Identification of human activin and TGF-β type I receptors that form heteromeric kinase complexes with type II receptors. Cell 75: 671-680, 1993.
2. Attisano, L., J. L. Wrana, S. Cheifetz, and J. Massagué. Novel activin receptors: distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptors. Cell 68: 97-108, 1992.
3. Cárcamo, J., A. Zentella, and J. Massagué. Disruption of TGF-β signaling by a mutation that prevents transphosphorylation within the receptor complex. Mol. Cell. Biol. 15: 1573-1581, 1995.
4. Chen, F., and R. A. Weinberg. Biochemical evidence for the autophosphorylation and transphosphorylation of transforming growth factor β receptor kinases. Proc. Natl. Acad. Sci. USA 92: 1565-1569, 1995.
5. Choi, M. E., and B. J. Ballermann. Inhibition of capillary morphogenesis and associated apoptosis by dominant negative mutant transforming growth factor-β receptors. J. Biol. Chem. 270: 21144-21150, 1995.
6. Choi, M. E., A. Liu, and B. J. Ballermann. Differential expression of transforming growth factor-β receptors in rat kidney development. Am. J. Physiol. 273 (Renal Physiol. 42): F386-F395, 1997.
7. Dionne, C. A., G. Crumley, F. Bellot, J. M. Kaplow, G. Searfoss, M. Ruta, W. H. Burgess, M. Jaye, and J. Schlessinger. Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors. EMBO J. 9: 2685-2692, 1990.
8. Duan, D.-S., S. Werner, and L. T. Williams. A naturally ocurring secreted form of fibroblast growth factor (FGF) receptor 1 binds basic FGF in preference over acidic FGF. J. Biol. Chem. 267: 16076-16080, 1992.
9. Ebner, R., R.-H. Chen, L. Shum, S. Lawler, T. F. Zioncheck, A. Lee, A. R. Lopez, and R. Derynck. Cloning of a type I TGF-β receptor and its effect on TGF-β binding to the type II receptor. Science 260: 1344-1348, 1993.
10. Estevez, M., L. Attisano, J. L. Wrana, P. S. Albert, J. Massagué, and D. L. Riddle. The daf-4 gene encodes a bone morphogenetic protein receptor controlling C. elegans larva development. Nature 365: 644-649, 1993.
11. Franchimont, N., S. Rydziel, A. M. Delany, and E. Canalis. Interleukin-6 and its soluble receptor cause a marked induction of collagenase 3 expression in rat osteoclasts cultures. J. Biol. Chem. 272: 12144-12150, 1997.
12. Franzén, P., P. ten Dijke, H. Ichijo, H. Yamashita, P. Schulz, C. H. Heldin, and K. Miyazono. Cloning of a TGFβ type I receptor that forms a heteromeric complex with the TGFβ type II receptor. Cell 75: 681-692, 1993.
13. Johnson, D. E., J. Lu, H. Chen, S. Werner, and L. T. Williams. The human fibroblast growth factor receptor genes: a common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglobulin domain. Mol. Cell. Biol. 11: 4627-4634, 1991.
14. Kendall, R. L., and K. A. Thomas. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc. Natl. Acad. Sci. USA 90: 10705-10709, 1993.
15. Lin, H. Y., W-F. Wang, E. Ng-Eaton, R. A. Weinberg, and H. F. Lodish. Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 68: 775-785, 1992.
16. Markowitz, S. D., and A. B. Roberts. Tumor suppressor activity of the TGF-β pathway in human cancers. Cytokine Growth Factor Rev. 7: 93-102, 1996.
17. Miki, T., T. P. Fleming, D. P. Bottaro, J. S. Rubin, D. Ron, and S. A. Aaronson. Expression cDNA cloning of the KGF receptor by creation of a transforming autocrine loop. Science 251: 72-75, 1991.
18. Mosley, B., M. P. Beckmann, C. J. March, R. L. Idzerda, S. D. Gimpel, T. VandenBos, D. Friend, A. Alpert, D. Anderson, J. Jackson, J. M. Wignall, C. Smith, B. Gallis, J. E. Sims, D. Urdal, M. B. Widmer, D. Cosman, and L. S. Park. The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms. Cell 59: 335-348, 1989.
19. Roelen, B. A., H. Y. Lin, V. Knezevic, E. Freund, and C. L. Mummery. Expression of TGF-βs and their receptors during implantation and organogenesis of the mouse embryo. Dev. Biol. 166: 716-728, 1994.
20. Saitoh, M., H. Nishitoh, T. Amagasa, K. Miyazono, M. Takagi, and H. Ichijo. Identification of important regions in the cytoplasmic juxtamembrane domain of type I receptor that separate signaling pathways of transforming growth factor-β. J. Biol. Chem. 271: 2769-2775, 1996.
21. Ten Dijke, P., H. Yamashita, H. Ichijo, P. Franzen, M. Laiho, K. Miyazono, and C. H. Heldin. Characterization of type I receptors for transforming growth factor-beta and activin. Science 264: 101-104, 1994.
22. Ten Dijke, P., H. Yamashita, T. K. Sampath, A. H. Reddi, M. Estevez, D. L. Riddle, H. Ichijo, C. H. Heldin, and K. Miyazono. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J. Biol. Chem. 269: 16985-16988, 1994.
23. Tiesman, J., and C. E. Hart. Identification of a soluble receptor for platelet-derived growth factor in cell-conditioned medium and human plasma. J. Biol. Chem. 268: 9621-9628, 1993.
24. Vellucci, V. F., and M. Reiss. Cloning and genomic organization of the human transforming growth factor-β type I receptor gene. Genomics 46: 278-283, 1997.
25. Weis-Garcia, F., and J. Massagué. Complementation between kinase-defective and activation-defective TGF-β receptors reveals a novel form of receptor cooperativity essential for signaling. EMBO J. 15: 276-289, 1996.
26. Wrana, J. L., L. Attisano, J. Cárcamo, A. Zentella, J. Doody, M. Laiho, X. F. Wang, and J. Massagué. TGF-β signals through a heteromeric protein kinase receptor complex. Cell 71: 1003-1014, 1992.
27. Wrana, J. L., L. Attisano, R. Wieser, F. Ventura, and J. Massagué. Mechanism of activation of the TGF-β receptor. Nature 370: 341-347, 1994.
28. Yamashita, H., P. ten Dijke, P. Franzén, K. Miyazono, and C.-H. Heldin. Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-β. J. Biol. Chem. 269: 20172-20178, 1994.